Viral myocarditis--diagnosis, treatment options, and current controversies (Q38551013)

4 September 2017

1 reference

title

Viral myocarditis--diagnosis, treatment options, and current controversies (English)

1 reference

4 September 2017

Valentín Fuster Carulla

series ordinal

3

1 reference

4 September 2017

Ari Pollack

1

1 reference

4 September 2017

Amy R Kontorovich

series ordinal

2

1 reference

4 September 2017

G William Dec

series ordinal

4

1 reference

4 September 2017

language of work or name

English

0 references

publication date

21 July 2015

1 reference

Nature Reviews Cardiology

4 September 2017

1 reference

4 September 2017

12

1 reference

4 September 2017

670-680

1 reference

4 September 2017

11

1 reference

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

4 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Diagnosis and treatment of viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Myocarditis: current trends in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Incidence, causes, and outcomes of dilated cardiomyopathy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Diagnosis of myocarditis: death of Dallas criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

21 January 2018

Update on myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

The organisms reported to cause infective myocarditis and pericarditis in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Adenovirus myocarditis in mice. An electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Viral persistence in the myocardium is associated with progressive cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Virus serology in patients with suspected myocarditis: utility or futility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Viral myocarditis mimicking acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Long-term evolution and prognostic stratification of biopsy-proven active myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Visualization of immune cell infiltration in experimental viral myocarditis by (19)F MRI in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Development and characterization of an antibody-labeled super-paramagnetic iron oxide contrast agent targeting prostate cancer cells for magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

EANM/SNMMI guideline for 18F-FDG use in inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

21 January 2018

Acute viral myocarditis

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Combined immunosuppression for the treatment of idiopathic giant cell myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Human herpesvirus-6: a short review of its biological behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Viral infection and the pathogenesis of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Autoantibodies and serum inhibition factors (sif) in patients with myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

The group B coxsackieviruses and myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Gamma-globulin treatment of acute myocarditis in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Human parvovirus B19-associated myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Echocardiographic findings in fulminant and acute myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Presentation, patterns of myocardial damage, and clinical course of viral myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Soci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Lymphocytic myocarditis and dilated cardiomyopathy: treatment with immunosuppressive agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Mortality in primary and secondary myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Treatment of systemic lupus erythematosus by extracorporeal immunoadsorption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.108

Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.

31 March 2020

1 reference

12 December 2020

Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis

1 reference

12 December 2020

The coxsackievirus and adenovirus receptor.

1 reference

12 December 2020

Myocarditis. A histopathologic definition and classification

1 reference

12 December 2020

Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets.

1 reference

12 December 2020

Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates

1 reference

12 December 2020

Causes of sudden cardiac death in young Australians.

1 reference

12 December 2020

10.1038/NRCARDIO.2015.108

Identifiers

DOI

1 reference

4 September 2017

1 reference